SINBON Pharmaceutical has medical institutions such as the Affiliated Cancer Hospital of Guizhou Medical University.
* |Guiyin Financial Comprehensive Photo |SINBON Pharmaceutical.
The A-share listed company "SINBON Pharmaceutical" in Guizhou has ushered in a new senior management team.
On February 21, SINBON Pharmaceutical issued the "Announcement on the Appointment of Senior Managers and Other Relevant Personnel of the Company".
Announcement Disclosure:Nominated by the chairman of the board of directors and reviewed by the nomination committee of the board of directors, Kong Lingzhong was appointed as the general manager of the company.
Nominated by the general manager of the company and reviewed by the nomination committee of the board of directors, Zhang Jieqing, Chen Chuan, Lu Yafang, Xiao Yayun and Luo Chi were appointed as deputy general managers of the company.
Nominated by the general manager of the company and reviewed by the nomination committee of the board of directors, Xiao Yajun was appointed as the company's chief financial officer.
Nominated by the chairman of the board of directors and reviewed by the nomination committee of the board of directors, Chen Chuan was appointed as the secretary of the board of directors of the company.
Nominated by the Audit Committee of the Board of Directors of the Company, reviewed by the Audit Committee and the Nomination Committee of the Board of Directors, Yu Zhaofei was appointed as the head of the internal audit department of the Company.
Nominated by the chairman of the board of directors and reviewed by the nomination committee of the board of directors, Chen Chuan was appointed as the company's first affairs representative.
According to the official website, Guizhou Xinbang Pharmaceutical Co., Ltd. was established in 1995 and listed on the Shenzhen Stock Exchange in April 2010.
The Company owns medical institutions such as the Affiliated Cancer Hospital of Guizhou Medical University, the Affiliated Baiyun Hospital, and the Affiliated Wudang Hospital, as well as holding subsidiaries such as Guizhou Kekai Pharmaceutical Co., Ltd. and Guizhou Tongde Pharmaceutical Co., Ltd.
SINBON Pharmaceutical's third quarter report of 2023 shows that from January to September, the company's operating income was 482.3 billion yuan, a year-on-year increase of 292%；Net profit attributable to shareholders of listed companies24.7 billion yuan, a year-on-year increase of 230%。
Special note: The content is for reference only and does not constitute investment advice. If the article or ** involves copyright and other issues, please contact Long Ding'an, the perennial legal counsel of Guizhou Wenjiajin Law Firm.
Looking back on the past
The senior management of Guizhou Jinsha Liquor Co., Ltd., a state-owned enterprise China Resources Holdings, has changed, and Wei Qiang is the chairman.
It's being announced! 132 private entrepreneurs in Guizhou are to be commended.
The qualifications of a number of directors and independent directors of Guiyang Bank were approved.